Back to search results

Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity

Abroad (travel likely)RecruitingPHASE2

Conditions

Retinopathy of Prematurity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University Hospital Tübingen, Tübingen, Baden-Wurttemberg, Germany

    Contact: Study coordinator (Axel R Franz, Prof.)

  • University Hospital Zurich, Zurich, Canton of Zurich, Switzerland

    Contact: Study coordinator (Christoph M Rüegger) · christoph.rueegger@usz.ch · +41432539810
    Contact: Study coordinator (Claudia Knoepfli) · claudia.knoepfli@usz.ch
    Contact: Principal Investigator (Christoph Rüegger)
    David Glauser (Sub-investigator)

  • Ankara University School of Medicine Children's Hospital, Ankara, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Ömer Erdeve, Prof.)
Study leads

  • Dirk Bassler, M.D.

    Principal Investigator

    University of Zurich

View source on ClinicalTrials.gov(opens in a new tab)